Speaker Profile
Ph.D., MBA, Chief Executive Officer, Paige
Biography
Dr. Andy Moye is a seasoned commercial leader and corporate development executive who has worked across the molecular diagnostics, biotechnology and life sciences industries. He is currently Chief Executive Officer at Paige and previously served as Chief Commercial Officer, where he led the company’s clinical sales and commercial strategy, including the U.S. launch of Paige Prostate, the first and only AI-based pathology product to receive FDA approval for in vitro diagnostic (IVD) use in detecting cancer in prostate biopsies. Previously, Dr. Moye served as Head of Commercial Operations in North America and Latin America for the Digital and Computational Pathology division of Philips, delivering significant growth in both markets for the emerging business. Dr. Moye has also served in executive roles at leading healthcare companies including Ontada, a division of McKesson, Caris Life Sciences, and WaferGen Bio-systems, now part of Takara Bio.
Session Abstract – PMWC 2022 Silicon Valley
Track Chairs:
Sharmila Majumdar, UCSF
The use of Artificial Intelligence (AI) in diagnostic medical imaging is undergoing extensive evaluation. AI has shown impressive accuracy and sensitivity in the identification of imaging abnormalities and promises to enhance tissue-based detection and characterization. This track will explore technical advancements in clinical machine learning and use cases in radiology.
Sessions:
- AI Roadmap: Opportunities and Challenges (PANEL)
Session Chair: Sean Khozin, CancerLinQ
- Matthew Lungren, AWS
- Patrick Loerch, Gilead
- Greg Yap, Menlo Ventures
- Lydia The, McKinsey & Company
- Chris Gibson, Recursion
- Andrea Mazzocchi, Known Medicine - Actionable AI: Empowering the Stewards of Precision Medicine
- Martin Stumpe, Tempus - Technical Advancements in Clinical Machine Learning - What's New in 2022 (PANEL)
Session Chair: Sharmila Majumdar, UCSF
- Matthew Lungren, AWS - Jayashree Kalpathy-Cramer, Harvard
- John Mongan, UCSF - Image Applications for Clinical Diagnosis
Session Chair: Esther L. Yuh, UCSF
- Thorsten Fleiter, U. of Maryland
- Imon Banerjee, Mayo Clinic
- Pratik Mukherjee, UCSF
- Lawrence Schwartz, Columbia University Medical Center
- Rakesh Shiradkar, Case Western Reserve University - The Impact of AI and High-Resolution Digital Slide Imaging
Session Chair: Ryan Davis, Epredia
- Andy Moye, Paige
- Thomas Westerling-Bui, Aiforia
Session Chair: Fatemeh Zabihollahy, UCLA
- Mirabela Rusu, Stanford
- Mona Flores, NVIDIA
- Kilian Koepsell, Caption Health
- Eric Horler, AIQ Solutions
